Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BIOR - BIORA THERAPEUTICS, INC.

0.5461
-0.214   -39.169%

Share volume: 0
Last Updated: Tue 10 Dec 2024 09:29:11 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): -0.07%

PREVIOUS CLOSE
CHG
CHG%
$0.76
-0.21
-28.14%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
34%
Profitability 50%
Dept financing 43%
Liquidity 13%
Performance 20%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
-58.54%
3 Months
-1.46%
6 Months
-15.20%
1 Year
-56.27%
2 Year
-73.47%
Key data
Stock price
$0.55
P/E Ratio 
-0.29
DAY RANGE
$0.65 - $0.74
EPS 
-$2.41
52 WEEK RANGE
$0.51 - $5.69
52 WEEK CHANGE
-$56.27
MARKET CAP 
25.415 M
YIELD 
N/A
SHARES OUTSTANDING 
36.469 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.49
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
$977,734
Company detail
CEO: Aditya P. Mohanty
Region: US
Website: bioratherapeutics.com
Employees: 120
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

Recent news